NSCI — Nanalysis Scientific Income Statement
0.000.00%
Last trade - 00:00
- CA$49.16m
- CA$66.01m
- CA$24.82m
- 35
- 38
- 68
- 44
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 8.38 | 8.36 | 7.87 | 16 | 24.8 |
Cost of Revenue | |||||
Gross Profit | 5.4 | 6.06 | 5.17 | 10.2 | 11.1 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 8.34 | 9.55 | 11.6 | 17.4 | 35.1 |
Operating Profit | 0.04 | -1.19 | -3.68 | -1.38 | -10.2 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 0.136 | -0.973 | -3.98 | -1.77 | -10.4 |
Provision for Income Taxes | |||||
Net Income After Taxes | 0.074 | -1.23 | -3.68 | -1.77 | -9.91 |
Net Income Before Extraordinary Items | |||||
Net Income | 0.074 | -1.23 | -3.68 | -1.77 | -9.91 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 0.074 | -1.23 | -3.68 | -1.77 | -9.91 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.002 | -0.007 | -0.054 | -0.022 | -0.106 |